• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆碱能性荨麻疹患者的不同年龄组具有不同的特征。

Cholinergic urticaria patients of different age groups have distinct features.

机构信息

Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Clin Exp Allergy. 2017 Dec;47(12):1609-1614. doi: 10.1111/cea.13023. Epub 2017 Oct 10.

DOI:10.1111/cea.13023
PMID:28873238
Abstract

BACKGROUND

Cholinergic urticaria (CholU) is a common skin disease characterized by the development of pinpoint-sized weals and severe itch upon physical exercise. Little is known about the epidemiology of CholU. CholU can occur at any age and has the highest prevalence among young adults. As of now, it is unclear whether patients of different age show differences in the clinical manifestation of CholU, duration of disease, comorbidities or response to treatment.

METHODS

Here, we analysed the demographic data and clinical characteristics including disease duration and comorbidities of 200 patients with CholU, 12-76 years of age.

RESULTS

We identified two distinct types of CholU, one with early onset (EO, 71%) and one with late onset (LO, 29%). Patients with EO and LO CholU markedly differ in key characteristics: patients with EO, who had a disease onset before the age of 36, showed no gender preponderance and had a significantly higher rate of concomitant atopic dermatitis (16.9% vs 5.2%; P = .028) and higher IgE levels (295.5 vs 267.1 IU/mL; P = .020) as compared to patients with LO, who were mainly female (69%), had a shorter duration of disease (33.3 vs 63.7 months; P = .005), a higher rate of concomitant other forms of urticaria (48.3% vs 33.1%; P = .044) and a higher rate of psychiatric comorbidities (12.1% vs 1.4%; P = .001).

CONCLUSION

There are two subtypes of CholU patients with different gender ratios, disease duration and comorbidities. These findings suggest that two distinct underlying pathogenetic pathways are relevant in these two subgroups of patients with CholU.

摘要

背景

胆碱能性荨麻疹(CholU)是一种常见的皮肤病,其特征是在进行体力活动时会出现针尖大小的风团和剧烈瘙痒。关于 CholU 的流行病学知之甚少。CholU 可发生于任何年龄,在年轻人中患病率最高。目前尚不清楚不同年龄的患者在 CholU 的临床表现、疾病持续时间、合并症或对治疗的反应是否存在差异。

方法

在此,我们分析了 200 名年龄在 12-76 岁的 CholU 患者的人口统计学数据和临床特征,包括疾病持续时间和合并症。

结果

我们发现 CholU 有两种不同的类型,一种是早发型(EO,71%),另一种是晚发型(LO,29%)。EO 和 LO CholU 患者在关键特征上存在显著差异:EO 患者发病年龄在 36 岁之前,无明显性别优势,特应性皮炎合并率显著较高(16.9% vs 5.2%;P =.028),IgE 水平也显著较高(295.5 vs 267.1 IU/mL;P =.020);而 LO 患者主要为女性(69%),发病年龄较晚(33.3 个月 vs 63.7 个月;P =.005),合并其他类型荨麻疹的比例较高(48.3% vs 33.1%;P =.044),合并精神疾病的比例也较高(12.1% vs 1.4%;P =.001)。

结论

CholU 患者存在两种不同的亚型,其性别比例、疾病持续时间和合并症不同。这些发现提示 CholU 的这两个亚组患者存在两种不同的潜在发病机制。

相似文献

1
Cholinergic urticaria patients of different age groups have distinct features.胆碱能性荨麻疹患者的不同年龄组具有不同的特征。
Clin Exp Allergy. 2017 Dec;47(12):1609-1614. doi: 10.1111/cea.13023. Epub 2017 Oct 10.
2
Atopic predisposition in cholinergic urticaria patients and its implications.胆碱能性荨麻疹患者的特应性易感性及其意义。
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2060-2065. doi: 10.1111/jdv.13765. Epub 2016 Jun 21.
3
Cholinergic Urticaria: Clinical Presentation and Natural History in a Tropical Country.胆碱能性荨麻疹:热带国家的临床特征和自然病史。
Biomed Res Int. 2020 May 24;2020:7301652. doi: 10.1155/2020/7301652. eCollection 2020.
4
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.胆碱能性荨麻疹中靶向组胺受体 4 的 izuforant(LEO 152020):一项 IIa 期随机、双盲、安慰剂对照、多中心交叉试验的结果。
Br J Dermatol. 2024 May 17;190(6):825-835. doi: 10.1093/bjd/ljae038.
5
Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL).胆碱能性荨麻疹生活质量问卷(CholU-QoL)的编制与验证。
Clin Exp Allergy. 2018 Apr;48(4):433-444. doi: 10.1111/cea.13102. Epub 2018 Feb 28.
6
Acetylcholine-induced whealing in cholinergic urticaria - What does it tell us?乙酰胆碱诱导性风团在胆碱能性荨麻疹中的意义是什么?
J Dermatol Sci. 2021 Jul;103(1):10-15. doi: 10.1016/j.jdermsci.2021.05.001. Epub 2021 May 7.
7
Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria.开发一种用于诊断和研究胆碱能性荨麻疹的标准化脉搏控制运动试验。
J Dermatol Sci. 2014 Aug;75(2):88-93. doi: 10.1016/j.jdermsci.2014.04.007. Epub 2014 May 1.
8
Cholinergic Urticaria: Subtype Classification and Clinical Approach.胆碱能性荨麻疹:亚型分类与临床处理方法。
Am J Clin Dermatol. 2023 Jan;24(1):41-54. doi: 10.1007/s40257-022-00728-6. Epub 2022 Sep 15.
9
Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.胆碱能性荨麻疹患者的出汗功能障碍与汗腺中乙酰胆碱受体 CHRM3 和乙酰胆碱酯酶表达降低有关。
Front Immunol. 2022 Jul 29;13:955161. doi: 10.3389/fimmu.2022.955161. eCollection 2022.
10
A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.日本基层医疗机构1061例荨麻疹患者的亚型及临床特征调查
J Dermatol. 2022 Dec;49(12):1255-1262. doi: 10.1111/1346-8138.16562. Epub 2022 Aug 26.

引用本文的文献

1
Exercise-Induced Angioedema, Urticaria, and Anaphylaxis-A Narrative Review.运动诱发的血管性水肿、荨麻疹和过敏反应——一篇叙述性综述
Sports (Basel). 2025 Jul 3;13(7):215. doi: 10.3390/sports13070215.
2
Chronic inducible urticaria - having more than one is common and clinically relevant.慢性诱导性荨麻疹——存在多种类型很常见且具有临床相关性。
Front Immunol. 2025 Jun 30;16:1584771. doi: 10.3389/fimmu.2025.1584771. eCollection 2025.
3
Case Report: Hives and faints, an unusual affair.病例报告:荨麻疹和晕厥,不寻常的事件。
F1000Res. 2024 Jul 9;12:1193. doi: 10.12688/f1000research.141339.2. eCollection 2023.
4
New insights into chronic inducible urticaria.慢性诱导性荨麻疹的新见解。
Curr Allergy Asthma Rep. 2024 Aug;24(8):457-469. doi: 10.1007/s11882-024-01160-y. Epub 2024 Jul 19.
5
Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement.荨麻疹的免疫发病机制:组胺和细胞因子参与的临床观点。
Inflamm Res. 2024 May;73(5):877-896. doi: 10.1007/s00011-024-01869-6. Epub 2024 Mar 31.
6
The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.性与性别在皮肤病学中的作用——从发病机制到临床意义。
J Cutan Med Surg. 2023 Jul-Aug;27(4):NP1-NP36. doi: 10.1177/12034754231177582. Epub 2023 Jul 4.
7
Urticaria.荨麻疹。
Nat Rev Dis Primers. 2022 Sep 15;8(1):61. doi: 10.1038/s41572-022-00389-z.
8
Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.胆碱能性荨麻疹患者的出汗功能障碍与汗腺中乙酰胆碱受体 CHRM3 和乙酰胆碱酯酶表达降低有关。
Front Immunol. 2022 Jul 29;13:955161. doi: 10.3389/fimmu.2022.955161. eCollection 2022.
9
Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries.德语国家胆碱能性荨麻疹患者的疾病影响、诊断延迟及未满足的医疗需求
Front Allergy. 2022 May 25;3:867227. doi: 10.3389/falgy.2022.867227. eCollection 2022.
10
Cholinergic Urticaria: Clinical Presentation and Natural History in a Tropical Country.胆碱能性荨麻疹:热带国家的临床特征和自然病史。
Biomed Res Int. 2020 May 24;2020:7301652. doi: 10.1155/2020/7301652. eCollection 2020.